stocktitan.netOCT 151 min read$ZD

The earnings release is set for Thursday evening; Ziff Davis' public webcast follows Friday morning.

Ziff Davis (NASDAQ: ZD) will release its Q3 2026 earnings on November 5, followed by an earnings call on November 6. CEO Vivek Shah and CFO Bret Richter will host the call, which will be webcast and archived on the company's website. Ziff Davis is a digital media and internet company with brands in technology, gaming, and other sectors.

Original reporting

stocktitan.net

Published Oct 15, 2026, 11:00 AM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Oct 15, 2026, 11:02 AM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

AlphAI market briefEarnings

Primary signal

$ZD

Neutral

high confidence

Mentioned

$ZD

Relevance

5/10

AlphAI data visualization · based on stocktitan.net

Decision brief

The 30-second read

$ZDNeutralLow

Why it matters

The filing itself does not move the stock; price action will depend on the actual earnings results.

Market read

The news is relevant for traders monitoring upcoming earnings releases but offers no immediate trade signal.

What to watch

Potential hidden guidance or surprise in the upcoming release.

Relevance 5/10Novelty 4/10Timing: ahead of the Nov 5 earnings release

Background

Ziff Davis is a NASDAQ-listed digital media company. The announcement is a standard 8‑K filing informing investors of its upcoming earnings schedule.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$ZDNeutralHigh confidence

Context

Ziff Davis announced its Q3 2026 earnings release date (Nov 5) and call (Nov 6).

Expected impact

neutral as the market awaits the earnings numbers

Evidence & confidence

No new financial data is provided; investors typically wait for the actual results before moving the price.

Market effects

Sector

Sets a timeline for the digital media sector's earnings season.

Regional

Minimal impact on broader US market.

Global

Limited to investors tracking media stocks.

Counterpoint

What could challenge this read

Some traders may short ahead of earnings if they expect a miss.

Key entities

Company
Ziff Davis, Inc.
Digital media and internet company (NASDAQ: ZD).

Read at source ← All news

AUG 14

$ZDMedAI 8/10

Ziff Davis (ZD) Q2 2026 Earnings Call Transcript

Ziff Davis (ZD) reported Q2 2026 revenue of $286.7 million, down 2.7% YoY, and adjusted EBITDA of $76.8 million, down 3.7% with a 26.8% margin. Adjusted diluted EPS rose to $1.03 on lower share count. The company sold Connectivity to Accenture for $1.2 billion, repurchased 2.6M shares for $121.5M, and expects sequential Q3 revenue growth.

fool.com6 min

AUG 9

$ZDMed

Ziff Davis Q2 Earnings Call Highlights

Ziff Davis (NASDAQ:ZD) reported Q2 call highlights. Advertising and performance-marketing revenue fell 6% YoY and subscription and licensing revenue was flat. Other revenue rose over 2x, up about $3.7M, mainly from Semantic Labs. Cash was $1.6B and long-term investments $100M. The company accelerated buybacks, repurchasing 2.6M shares for $121.5M, and expects Q3 revenue to rise sequentially but fall YoY.

yahoo.com6 min

AUG 6

$ZDMed

Ziff Davis Reports Second Quarter 2026 Financial Results

ZIFF DAVIS, INC. (ZD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ziff Davis Reports Second Quarter 2026 Financial Results NEW YORK, NY -- August 6, 2026 -- Ziff Davis, Inc. (NASDAQ: ZD) (“Ziff Davis” or “the Company”) today reported unaudited financial results for the second quarter ended June 30, 2026. “With the successful sale o

SEC EDGAR 8-K6 min

JUN 17

$ZDLow

ZIFF DAVIS, INC. (ZD): Completion of Acquisition or Disposition of Assets

ZIFF DAVIS, INC. (ZD) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. EX-10.1 2 exhibit101ziffdavis-connec.htm EX-10.1 Document EXHIBIT 10.1 June 15, 2026 Reference is made to the Credit Agreement, dated as of April 7, 2021 (as the same has been amended, and as the same may be amended, restated, supplemented or otherwise modified from time to time,

SEC EDGAR 8-K3 min

OCT 25

$RDYMed

Dr Reddy's Laboratories Ltd (RDY) (Q2 2027) Earnings Call Highlights: Margin Recovery

Dr. Reddy's Laboratories reported a 1.5% year-over-year revenue decline, driven by lower lenalidomide sales and declines in North America, Europe, and PSAI businesses. The company expects margins to improve with new products and business mix, targeting a 55% gross margin. Semaglutide relaunch is planned for November 2026, and abatacept biosimilar approval is expected by December 2026.

finance.yahoo.com3 min